|
Philips Respironics is correcting software and updating the User Manual for Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve several previously reported safety issues that may affect the device’s ability to support patient breathing.
The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. This recall involves correcting software and labeling for certain devices, and does not involve removing them from where they are used or sold. This device may cause serious injury or death if you continue to use it without correction or without following the updated instructions.
Questions?
Customers in the U.S. with questions about this recall should contact respironics.service.operations@philips.com or their Philips representative at 1-800-722-9377.
|
|
|
|